However, the contrasting prognostic implications of high DSN1 expression in these two cancers during immunotherapy—favorable in BLCA and unfavorable in SKCM—highlight the critical influence of the specific tumor immune microenvironment. Here, DSN1 is linked to bladder transitional cell carcinoma.